The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Accusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltration



Nikkiso Belgium bvbaPA2021/001/001

Main Information

Trade NameAccusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltration
Active SubstancesSodium chloride
Calcium chloride
Magnesium chloride
Sodium bicarbonate
Dosage FormSolution for haemofiltration
Licence HolderNikkiso Belgium bvba
Licence NumberPA2021/001/001

Group Information

ATC CodeB05ZB Hemofiltrates

Status

Authorised/WithdrawnAuthorised
Licence Issued28/04/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

« Back